Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Molecular Biology›Molecular Dynamics Simulation
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Molecular Dynamics Simulation

Molecular Biology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed9 referencesApproximately 3 min read

A computer simulation developed to study the motion of molecules over a period of time.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 3 complete abstracts (632 words), 9 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A computer simulation developed to study the motion of molecules over a period of time.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Dynamics Simulation, Molecular; Dynamics Simulations, Molecular; Simulation, Molecular Dynamics; Simulations, Molecular Dynamics; Molecular Dynamics Simulations; Molecular Dynamics; Dynamic, Molecular; Dynamics, Molecular.

Where it fits in the MeSH classification

Broader topics
Models, Molecular; Molecular Structure; Computer Simulation

Research landscape

PubMed indexes 64,035 records tagged with the MeSH heading “Molecular Dynamics Simulation” (counts retrieved 2026-10-29). 31,676 of them (49.5%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 32,512 records.

Reviews account for 2,298 records (3.6%) and meta-analyses for 17. Randomized controlled trials number 5 (0.0%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 0 records; 2000-2009: 575 records; 2010-2019: 32,512 records; 2020 onward: 31,676 records0through 19995752000-200932,5122010-201931,6762020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 19990
2000-2009575
2010-201932,512
2020 onward31,676
Share of records by publication typeReviews: 3.6 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.0 percentReviews3.6% (2,298)Meta-analyses0.0% (17)Randomized controlled trials0.0% (5)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 64,035 PubMed records
TypeRecordsShare
Reviews2,2983.6%
Meta-analyses170.0%
Randomized controlled trials50.0%

Method: PubMed query "Molecular Dynamics Simulation"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in molecular biology

Molecular biology establishes mechanisms through controlled experiments, often in simplified systems such as purified proteins, cultured cells or model organisms. Such work can show what is possible in a defined system, but whether a pathway matters in a whole organism or in human disease needs further evidence. Check the experimental system, whether findings were reproduced by independent groups, and whether the authors tested the mechanism directly or inferred it from correlation.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Decrypting cryptic pockets with physics-based simulations and artificial intelligence
Zhang S, Bowman GR
2026Review article
Design not recorded in structured metadata
9cc by
PMID 41604887 · DOI · PMC12959236
Dynamic architecture of mycobacterial outer membranes revealed by all-atom simulations
Brown TP, Chavent M, Im W
2026Research article
Design not recorded in structured metadata
6cc by
PMID 42090459 · DOI · PMC13148821
Destabilization of Structured RNAs by OPC and TIP4PD Water Models
Krepl M, Mlýnský V, Rusnáková A, Banáš P, Otyepka M, Šponer J
2026Research article
Design not recorded in structured metadata
6cc by
PMID 41665624 · DOI · PMC12937104

Decrypting cryptic pockets with physics-based simulations and artificial intelligence [1]

Review article Zhang S, Bowman GR · · 2026 · cited 9 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Cryptic pockets are promising targets for drug discovery that greatly expand the druggable proteome.
Closing excerpt
This review highlights key developments in computational approaches, including physics-based molecular dynamics simulations, artificial intelligence-driven models, and hybrid strategies that integrate both to enhance cryptic pocket discovery and functional interpretation.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (105 words)

Cryptic pockets are promising targets for drug discovery that greatly expand the druggable proteome. In particular, they can provide opportunities to target proteins previously thought to be "undruggable" due to a lack of pockets in structures of the ground state. However, their transient and hidden nature renders them difficult to detect through conventional experimental screening methods. Recent advances in computational methodologies and resources have greatly enhanced our ability to identify and characterize such elusive pockets. This review highlights key developments in computational approaches, including physics-based molecular dynamics simulations, artificial intelligence-driven models, and hybrid strategies that integrate both to enhance cryptic pocket discovery and functional interpretation.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41604887 · DOI · PMC12959236

Dynamic architecture of mycobacterial outer membranes revealed by all-atom simulations [2]

Research article Brown TP, Chavent M, Im W · · 2026 · cited 6 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Tuberculosis remains a global health crisis due to the resilience of Mycobacterium tuberculosis (Mtb), largely attributed to its unique cell envelope.
Closing excerpt
Our work provides a foundational framework for targeting the mycobacterial outer membrane in future drug development.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (176 words)

Tuberculosis remains a global health crisis due to the resilience of Mycobacterium tuberculosis (Mtb), largely attributed to its unique cell envelope. The impermeability and structural complexity of the outer membrane of this envelope, driven by mycolic acids and glycolipids, pose significant challenges for therapeutic intervention. Here, we present the first all-atom models of an Mtb outer membrane using molecular dynamics simulations. We demonstrate that α-mycolic acids adopt extended conformations to stabilize bilayers, with a phase transition near 338 K that underscores their thermal resilience. Lipids in the outer leaflet, such as PDIM and PAT, induce membrane heterogeneity, migrating to the interleaflet space and reducing lipid order. The simulated mycobacterial outer membrane has ordered inner leaflets and disordered outer leaflets, which contrasts with the outer membrane of Gram-negative bacteria. These findings reveal that PDIM- and PAT-driven lipid redistribution, reduced lipid order, and asymmetric fluidity gradients enable Mtb's outer membrane to resist host-derived stresses and limit antibiotic penetration, thereby promoting bacterial survival. Our work provides a foundational framework for targeting the mycobacterial outer membrane in future drug development.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42090459 · DOI · PMC13148821

Destabilization of Structured RNAs by OPC and TIP4PD Water Models [3]

Research article Krepl M, Mlýnský V, Rusnáková A, Banáš P, Otyepka M, Šponer J · · 2026 · cited 6 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The four-point OPC water model has recently gained a reputation as the preferred choice for molecular dynamics (MD) simulations of nucleic acids and proteins, providing more realistic reproduction of bulk physical properties of water than the older three-point models.
Closing excerpt
For at least some structured RNA systems, the three-point water models may provide more stable behavior in combination with current AMBER RNA force fields.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (351 words)

The four-point OPC water model has recently gained a reputation as the preferred choice for molecular dynamics (MD) simulations of nucleic acids and proteins, providing more realistic reproduction of bulk physical properties of water than the older three-point models. It has been shown to improve, for example, simulations of unstructured biomolecules such as RNA tetranucleotides or intrinsically disordered proteins. However, the performance for folded RNA structures was not specifically explored. Here we present extensive testing of the OPC water model on three different RNAs with intricate tertiary structures - the ribosomal L1 stalk RNA-protein protuberance, the mini tetraloop-tetraloop receptor (miniTTR-6) folded RNA, and the GAAA tetraloop-tetraloop receptor homodimer. The OPC performance is directly compared with SPC/E, TIP3P, and OPC3 water models using the OL3 AMBER RNA force field (FF). We found substantial effect of the water model on simulation behavior. For all three systems, we observe large-scale unfolding of the RNA, and even loss of the L1 stalk protein-RNA interface, when simulated with the OPC. In contrast, the simulations are entirely stable with the three-point water models. The underlying cause seems to be the higher affinity of the OPC waters to H-bond donor and acceptor groups of the RNA, which weakens the native solute-solute interactions. An identical issue is observed also for the similar and widely used TIP4PD water model combined with the DES-Amber RNA FF. Importantly, the structural consequences of these issues may range from significant structural perturbations to minimal or undetectable effects, depending on the RNA system. Accordingly, we do not claim that the imbalance in water-RNA interactions identified here is a general feature of all RNA molecules. Indeed, simulations of three additional, less structurally complex RNA systems revealed more balanced performance, with no observable differences between water models for the noncanonical 5S rRNA Loop E double helix. However, certain caution is warranted when using the four-point OPC and TIP4PD water models for simulations of structured RNAs, particularly those rich in 2'-OH hydroxyl-based tertiary interactions. For at least some structured RNA systems, the three-point water models may provide more stable behavior in combination with current AMBER RNA force fields.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 41665624 · DOI · PMC12937104

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Molecular Dynamics Simulation for All [4]
    Hollingsworth SA, Dror RO · Neuron · 2018 · cited 1,926 times (Europe PMC)
  • Research article Markov State Models: From an Art to a Science [5]
    Husic BE, Pande VS · J Am Chem Soc · 2018 · cited 663 times (Europe PMC)
  • Research article A Review on Applications of Computational Methods in Drug Screening and Design [6]
    Lin X, Li X, Lin X · Molecules · 2020 · cited 310 times (Europe PMC)
  • Research article Key Topics in Molecular Docking for Drug Design [7]
    Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP · Int J Mol Sci · 2019 · cited 308 times (Europe PMC)
  • Research article Biophysical experiments and biomolecular simulations: A perfect match? [8]
    Bottaro S, Lindorff-Larsen K · Science · 2018 · cited 231 times (Europe PMC)
  • Research article Bottom-up Coarse-Graining: Principles and Perspectives [9]
    Jin J, Pak AJ, Durumeric AEP, Loose TD, Voth GA · J Chem Theory Comput · 2022 · cited 211 times (Europe PMC)

References

  1. Zhang S, Bowman GR. Decrypting cryptic pockets with physics-based simulations and artificial intelligence. . 2026. PMID 41604887 · DOI · PMC12959236
  2. Brown TP, Chavent M, Im W. Dynamic architecture of mycobacterial outer membranes revealed by all-atom simulations. . 2026. PMID 42090459 · DOI · PMC13148821
  3. Krepl M, Mlýnský V, Rusnáková A, Banáš P, Otyepka M, Šponer J. Destabilization of Structured RNAs by OPC and TIP4PD Water Models. . 2026. PMID 41665624 · DOI · PMC12937104
  4. Hollingsworth SA, Dror RO. Molecular Dynamics Simulation for All. Neuron. 2018. PMID 30236283 · DOI · PMC6209097
  5. Husic BE, Pande VS. Markov State Models: From an Art to a Science. J Am Chem Soc. 2018. PMID 29323881 · DOI
  6. Lin X, Li X, Lin X. A Review on Applications of Computational Methods in Drug Screening and Design. Molecules. 2020. PMID 32197324 · DOI · PMC7144386
  7. Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP. Key Topics in Molecular Docking for Drug Design. Int J Mol Sci. 2019. PMID 31540192 · DOI · PMC6769580
  8. Bottaro S, Lindorff-Larsen K. Biophysical experiments and biomolecular simulations: A perfect match?. Science. 2018. PMID 30049874 · DOI
  9. Jin J, Pak AJ, Durumeric AEP, Loose TD, Voth GA. Bottom-up Coarse-Graining: Principles and Perspectives. J Chem Theory Comput. 2022. PMID 36070494 · DOI · PMC9558379

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Molecular StructureMolecular Biology
  • Amino Acid SequenceMolecular Biology
  • Binding SitesMolecular Biology
  • Catalytic DomainMolecular Biology
  • Clustered Regularly Interspaced Short Palindromic RepeatsMolecular Biology
  • Consensus SequenceMolecular Biology

All 100 articles in Molecular Biology →

At a glance

64,035
PubMed records on this heading
49%
published since 2020
2,298
review articles
5
randomized trials
9
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Molecular StructureMolecular Biology
  • Amino Acid SequenceMolecular Biology
  • Binding SitesMolecular Biology
  • Catalytic DomainMolecular Biology
  • Clustered Regularly Interspaced Short Palindromic RepeatsMolecular Biology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support